Bioavailability/Bioequivalence on Biopharmaceutical Products

The Bioavailability Bioequivalence Research Center aims to become a regional center of excellence for assuring the safety and efficacy of generic pharmaceutical products for human use. It plays a key role in the drug development period for both new drug products and their generic equivalents. These studies are also important in the post approval period in the presence of certain manufacturing changes. Information in the overall set of data that ensure the availability of safe and effective medicines to patients and practitioners can be discussed

  • Factors affecting bae
  • BABE studies
  • Assesssment of bioeqivalence
  • In vivo/In vitro studies
  • Latest Updates In BA/BE

Related Conference of Bioavailability/Bioequivalence on Biopharmaceutical Products

February 28-March 01, 2019 ANA Crowne Plaza |

Global Pharmaceutical and Pharma Industry Conference

Osaka, Japan
March 18-19, 2019

13th International Conference on Biosimilars and Biologics

Amsterdam | Netherlands
July 26-27, 2019

13th Asian Biologics and Biosimilars Congress

Mercure Albert Park | Melbourne, Australia

Bioavailability/Bioequivalence on Biopharmaceutical Products Conference Speakers

Recommended Sessions

Related Journals

Are you interested in